Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

VIVS vs DDD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DDD Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–1 Matrix Metrics)

DDD Overall Winner 6-Pillar Tally: VIVS 1 – 5 DDD Matrix Metrics: VIVS 1 – 8 DDD

As of Nov 19, 2026, 3D Systems Corporation (DDD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 39.0/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas DDD carries 57.8/100 (HOLD) at $1.48 (22.5x Forward P/E, -15.1% operating margin).

  • Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile DDD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VIVS vs DDD
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
TTM Revenue $112,000
Forward P/E N/M
Beta / 30D Vol 0.83β · 480% Vol
Unified Composite Score
39.0 / 100 SELL
Tech 5.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.1 · SMA20: $0.15 · SMA50: $0.18
DDD NYSE Head-to-Head Winner
3D Systems Corporation
Services-Prepackaged Software
$1.48
+7.25% 1D
Market Cap $250.2M
TTM Revenue $396M
Forward P/E 22.5x
Beta / 30D Vol 3.24β · 140% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 60.0 Fund 62.0 Flow 70.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -14.2%), weak momentum, RSI 26
RSI-14: 25.5 · SMA20: $2.18 · SMA50: $2.87

6-Pillar Scorecard Institutional Category Breakdown (VIVS 1 – 5 DDD)

Columns: Metric · VIVS · DDD
1. Valuation Multiples DDD
Forward P/E N/M 22.5x
Trailing P/E N/M 22.5x
PEG Ratio N/M 0.85x
EV / Revenue 9.6x 0.8x
2. Growth & Scale DDD
Revenue Growth (YoY) -51.4% +8.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $112,000 $396M
Market Cap $2.4M $250.2M
3. Profitability & Quality DDD
Gross Margin N/A 34.5%
Operating Margin -10117.0% -15.1%
Net Profit Margin 0.0% -17.8%
Return on Equity (ROE) -343.1% -30.0%
4. Balance Sheet & Cash Flow VIVS
Cash Generation (TTM) -$11M EBITDA -$48M
Cash Flow Margin N/A -12.3%
Net Cash / Leverage $1.4M Net Cash $51M Net Debt (0.58x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DDD
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile N/A (N/A) 104.4% (32nd %ile)
Put/Call OI Skew N/A 0.11x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat DDD
OpEx & R&D Intensity N/A 49.6% of Rev ($196M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Computer Hardware Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VIVS (1) vs DDD (8)
Institutional Metric VIVS DDD Criterion Row Edge
Market Capitalization
Scale
$2.4M $250.2M Larger Scale DDD
Trailing P/E Ratio
Valuation
N/M 22.5x Lower Multiple DDD
Forward P/E Ratio
Valuation
N/M 22.5x Lower Multiple DDD
Revenue Growth (YoY)
Growth
-51.4% +8.8% Higher Growth DDD
Operating Margin (TTM)
Profitability
-10117.0% -15.1% Higher Margin DDD
Net Profit Margin
Profitability
0.0% -17.8% Higher Margin VIVS
Return on Equity (ROE)
Capital Efficiency
-343.1% -30.0% Higher ROE DDD
52-Week Range Position
Momentum
5% ($0–$3) 6% ($1–$4) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
0.83β · 480% Vol 3.24β · 140% Vol Lower Realized Risk DDD
Unified Institutional Score
Composite Signal
39.0 / 100 (SELL) 57.8 / 100 (HOLD) Higher Composite DDD
Trailing 12M Revenue (USD)
Operating Scale
$112,000 $396M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 34.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.6x EV/Rev 0.85x PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($1.4M Net Cash) -$48M ($51M Net Debt (0.58x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VIVS +115.68 pp
VIVS: +64.69% · DDD: -50.99%
3M Horizon VIVS +55.53 pp
VIVS: +1.92% · DDD: -53.61%
6M Horizon DDD +27.75 pp
VIVS: -78.25% · DDD: -50.5%
1Y Horizon DDD +58.14 pp
VIVS: -86.99% · DDD: -28.85%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VIVS Revenue DDD Revenue VIVS Op. Margin DDD Op. Margin Margin Leader
FY2019 $0M $640M -882.4% -9.0% DDD
FY2020 $0M $560M -977.9% -21.3% DDD
FY2021 N/A $620M N/A -5.4% DDD
FY2022 $0M $540M -765.3% -21.7% DDD
FY2023 $0M $490M -4792.2% -83.2% DDD
FY2024 $0M $440M -13840.4% -63.0% DDD
FY2025 $0M $390M -8761.1% -24.8% DDD
FY2026 $0M N/A -8768.7% N/A VIVS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VIVS BREAKDOWN
73d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact VIVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DDD BREAKDOWN
119d in phase · OBV DISTRIBUTION
Current IV 104.4%
IV Percentile 32nd %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact DDD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VIVS Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.4M market capitalization and -10117.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
DDD Moat Profile Cyclical / Execution-Driven Positioning
Computer Hardware Operator
Competes within the Computer Hardware value chain with $250.2M market capitalization and -15.1% operating margin.
OpEx & R&D Reinvestment 49.6% of Rev ($196M)
90D Engineering Disclosures 0 Published

Investor FAQ VIVS vs DDD Key Questions & Quantitative Answers

As of Nov 19, 2026, 3D Systems Corporation (DDD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 39.0/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas DDD carries 57.8/100 (HOLD) at $1.48 (22.5x Forward P/E, -15.1% operating margin). Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile DDD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DDD leads the Growth & Scale pillar: VIVS posts -51.4% YoY revenue growth and +0.0% YoY earnings growth on $112,000 TTM revenue (N/A gross margin, -10117.0% operating margin), compared with DDD at +8.8% YoY revenue growth and +0.0% YoY earnings growth on $396M TTM revenue (34.5% gross margin, -15.1% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VIVS cumulative revenue shifted N/A while DDD shifted -39.1%. In operating R&D and SG&A reinvestment, VIVS deploys N/A (0 90-day corporate R&D disclosures) versus 49.6% of Rev ($196M) (0 disclosures) for DDD.

DDD screens cheaper on headline valuation multiples. VIVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (unreported EBITDA margin), whereas DDD trades at 22.5x Forward P/E, 22.5x Trailing P/E, 0.85x PEG, and 0.8x EV/Revenue (-12.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VIVS (-343.1% ROE) versus DDD (-30.0% ROE) capital efficiency.

In options market volatility and institutional positioning, VIVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.83β · 480% Vol realized risk). By comparison, DDD carries 104.4% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.24β · 140% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.